Benchmarking trial and EQA NGS in (hemato-)oncology.
; • Examine the ability of the validated/accredited NGS assays to accurately and reproducibly detect clinically relevant mutations (solid tumors) in each of the participating laboratories
; • Compare the performance of different NGS methods currently used (art. 33bis) by different laboratories in Belgium
; • Develop a national EQA program : same standard!